Immucell (ICCC) Construction in Progress (2009 - 2025)
Immucell's Construction in Progress was $534,270 in Q4 2025, down 76.9% from $2.32 million a year earlier and down 79.8% from the prior quarter.
Analysis
Immucell (ICCC) Construction in Progress (2009 - 2025) Analysis & Trends
From Q1 2009 onward, Immucell has reported Construction in Progress for 41 quarters.
- Construction in Progress has now declined for three consecutive years, with a four-year compound annual growth rate of -35.0% (FY2021 to FY2025).
- In earlier years, Construction in Progress was $2.32 million in FY2024 (-16.3%), $2.77 million in FY2023 (-24.5%), $3.67 million in FY2022 (+22.6%) and $2.99 million in FY2021.
- The Q4 2025 figure marks the lowest quarterly Construction in Progress since Q3 2018.
- Compared with a year earlier, Construction in Progress was higher in two of the last five quarters, with an average decline of 19.5%.
- The best year-over-year quarter for Construction in Progress over five years was Q4 2022 (growth of 22.6%); the worst was Q4 2025 (a decline of 76.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | - |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | - |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | - |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | - |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | - |
| 10 | Immucell | 102.43 Mn | 75.03 Mn | 3.56 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 534,270.00 |
| Sep 30, 2025 | 2.65 Mn |
| Mar 31, 2025 | 2.68 Mn |
| Dec 31, 2024 | 2.32 Mn |
| Sep 30, 2024 | 2.59 Mn |
| Jun 30, 2024 | 2.61 Mn |
| Mar 31, 2024 | 2.65 Mn |
| Dec 31, 2023 | 2.77 Mn |
| Sep 30, 2023 | 2.80 Mn |
| Dec 31, 2022 | 3.67 Mn |
| Sep 30, 2022 | 4.57 Mn |
| Jun 30, 2022 | 3.88 Mn |
| Mar 31, 2022 | 3.19 Mn |
| Dec 31, 2021 | 2.99 Mn |
| Sep 30, 2018 | 34,786.00 |
| Dec 31, 2017 | 8.32 Mn |
| Sep 30, 2017 | 17.11 Mn |
| Jun 30, 2017 | 13.32 Mn |
| Mar 31, 2017 | 7.48 Mn |
| Dec 31, 2016 | 3.69 Mn |
API Access
Immucell Construction in Progress API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=construction-in-progress&ticker=ICCC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "construction-in-progress", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=construction-in-progress&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();